Astria Therapeutics, Inc. (ATXS) Free Cash Flow by Year
Astria Therapeutics, Inc. recorded an outflow of $81.5M in free cash flow in fiscal year 2024. This represents a decrease of 19.1% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters Astria Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ATXS Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ATXS Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Astria Therapeutics, Inc. financials
Frequently Asked Questions
What was Astria Therapeutics, Inc.'s free cash flow in fiscal year 2024?
Astria Therapeutics, Inc. recorded an outflow of $81.5M in free cash flow in fiscal year 2024.
How fast is Astria Therapeutics, Inc.'s free cash flow growing?
Astria Therapeutics, Inc. (ATXS) free cash flow fell by 19.1% year over year, from -$68.5M to -$81.5M in fiscal year 2024.
How has Astria Therapeutics, Inc.'s free cash flow changed over the years?
Across the 12 fiscal years this page covers, Astria Therapeutics, Inc. (ATXS) free cash flow went from -$16.4M in fiscal year 2013 to -$81.5M in fiscal year 2024.
What was Astria Therapeutics, Inc.'s free cash flow in the most recent quarter?
Astria Therapeutics, Inc. (ATXS) reported -$32.3M in free cash flow in Q3 2025. This represents a decrease of 15.4% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Astria Therapeutics, Inc. (ATXS) reported on that line in every period on record.